Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.55 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.50 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | NPY1R | P25929 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | NPY2R | P49146 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.47 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.47 |
| ▸ | RXRA | P19793 | 1/20 | 0.43 |
| ▸ | PLK1 | P53350 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13729150 | 0.78 | HDAC1 (0.53) | HDAC8HDAC6SMN1; SMN2MAPTCYP1A1 | |
| SCHEMBL13729148 | 0.78 | HDAC1 (0.53) | HDAC8HDAC6SMN1; SMN2MAPTCYP1A1 | |
| SCHEMBL14515064 | 0.77 | BACE1 (0.62) | HDAC8HDAC6SMN1; SMN2MAPTALDH1A1 | |
| SCHEMBL14515068 | 0.77 | PARP1 (0.44) | HDAC8HDAC6SMN1; SMN2MAPTALDH1A1 | |
| SCHEMBL5433951 | 0.77 | HDAC8 (0.56) | HDAC8HDAC6SMN1; SMN2MAPTCYP1A1 | |
| SCHEMBL22229994 | 0.77 | CYP1A2 (0.40) | HDAC8SMN1; SMN2MAPTALDH1A1CYP1A2 | |
| SCHEMBL5598861 | 0.77 | HDAC8 (0.69) | HDAC8HDAC6SMN1; SMN2MAPTCYP1A1 | |
| SCHEMBL3007219 | 0.77 | HDAC8 (0.69) | HDAC8HDAC6SMN1; SMN2MAPTCYP1A1 | |
| SCHEMBL15958497 | 0.76 | PTGS2 (0.47) | HDAC8HDAC6SMN1; SMN2MAPTCYP1A1 | |
| SCHEMBL23069115 | 0.75 | HDAC8 (0.67) | HDAC8HDAC6SMN1; SMN2MAPTCYP1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11793064-B2 | Organic metal complex, and organic light emitting device and display apparatus using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-10-17 | — | — | US | disclosed |
| US-20170092882-A1 | ORGANIC METAL COMPLEX, AND ORGANIC LIGHT EMITTING DEVICE AND DISPLAY APPARATUS USING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-03-30 | — | — | US | disclosed |
| US-20170092882-A1 | ORGANIC METAL COMPLEX, AND ORGANIC LIGHT EMITTING DEVICE AND DISPLAY APPARATUS USING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-03-30 | — | — | US | disclosed |
| US-9554442-B2 | Organic metal complex, and organic light emitting device and display apparatus using the same | CANON KABUSHIKI KAISHA (JP) | 2017-01-24 | — | — | US | disclosed |
| US-9554442-B2 | Organic metal complex, and organic light emitting device and display apparatus using the same | CANON KABUSHIKI KAISHA (JP) | 2017-01-24 | — | — | US | disclosed |
| EP-2217607-B1 | ORGANIC METAL COMPLEX, AND ORGANIC LIGHT EMITTING DEVICE AND DISPLAY APPARATUS USING THE SAME | CANON KK (JP) | 2016-11-02 | — | — | EP | disclosed |
| US-20100219407-A1 | ORGANIC METAL COMPLEX, AND ORGANIC LIGHT EMITTING DEVICE AND DISPLAY APPARATUS USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2010-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100219407-A1 | ORGANIC METAL COMPLEX, AND ORGANIC LIGHT EMITTING DEVICE AND DISPLAY APPARATUS USING THE SAME | L1CAM, AP2M1, MRPL9 | HDAC8 4803/4885HDAC6 4673/4885SMN1; SMN2 2326/4885 |
| US-11793064-B2 | Organic metal complex, and organic light emitting device and display apparatus using the same | L1CAM, AP2M1, MRPL9 | HDAC8 4803/4885HDAC6 4673/4885SMN1; SMN2 2326/4885 |
| US-20170092882-A1 | ORGANIC METAL COMPLEX, AND ORGANIC LIGHT EMITTING DEVICE AND DISPLAY APPARATUS USING THE SAME | L1CAM, AP2M1, MRPL9 | HDAC8 4803/4885HDAC6 4673/4885SMN1; SMN2 2326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.